newsfilter
← Latest News
Business Wire·

FDA Approval of Edwards Lifesciences’ PASCAL Precision System Opens New Treatment Pathway for Patients With Tricuspid Valve Disease

EW

Recent FDA Approval of PASCAL Ace with Capture Clarity Simplifies Mitral TEER Procedures for Clinicians Edwards Lifesciences Corporation (NYSE:EW) today announced that the U.S. Food and Drug Administration (FDA) has